Gagnon Securities’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-66,957
| Closed | -$664K | – | 111 |
|
|
2023
Q1 | $664K | Sell |
66,957
-1,636,218
| -96% | -$16.2M | 0.14% | 58 |
|
|
2022
Q4 | $17M | Sell |
1,703,175
-83,310
| -5% | -$621K | 3.75% | 9 |
|
|
2022
Q3 | $9.84M | Sell |
1,786,485
-10,015
| -0.6% | -$55.5K | 2.16% | 18 |
|
|
2022
Q2 | $6.56M | Buy |
1,796,500
+266,588
| +17% | +$1.26M | 1.37% | 28 |
|
|
2022
Q1 | $9.26M | Sell |
1,529,912
-4,144
| -0.3% | -$25.3K | 1.51% | 25 |
|
|
2021
Q4 | $12.9M | Sell |
1,534,056
-6,872
| -0.4% | -$60K | 1.94% | 24 |
|
|
2021
Q3 | $14M | Sell |
1,540,928
-29,691
| -2% | -$255K | 2.07% | 22 |
|
|
2021
Q2 | $12.7M | Buy |
1,570,619
+3,825
| +0.2% | +$26.2K | 1.81% | 23 |
|
|
2021
Q1 | $8.63M | Buy |
1,566,794
+113,745
| +8% | +$563K | 1.31% | 27 |
|
|
2020
Q4 | $4.94M | Buy |
1,453,049
+409,967
| +39% | +$1.08M | 0.79% | 30 |
|
|
2020
Q3 | $1.76M | Buy |
1,043,082
+90,405
| +9% | +$136K | 0.38% | 43 |
|
|
2020
Q2 | $1.56M | Sell |
952,677
-58,779
| -6% | -$117K | 0.38% | 41 |
|
|
2020
Q1 | $1.94M | Buy |
1,011,456
+12,712
| +1% | +$33.4K | 0.66% | 34 |
|
|
2019
Q4 | $2.85M | Buy |
998,744
+32,910
| +3% | +$95.3K | 0.62% | 37 |
|
|
2019
Q3 | $3.18M | Buy |
965,834
+6,821
| +0.7% | +$21.6K | 0.75% | 35 |
|
|
2019
Q2 | $3.12M | Buy |
959,013
+95,853
| +11% | +$341K | 0.67% | 36 |
|
|
2019
Q1 | $3.23M | Buy |
863,160
+11,534
| +1% | +$40.4K | 0.7% | 36 |
|
|
2018
Q4 | $2.94M | Buy |
851,626
+491,703
| +137% | +$2.43M | 0.78% | 33 |
|
|
2018
Q3 | $2.58M | Sell |
359,923
-1,288
| -0.4% | -$10K | 0.59% | 35 |
|
|
2018
Q2 | $2.52M | Buy |
+361,211
| New | +$2.25M | 0.73% | 31 |
|
Gagnon Securities's APEN Position: Q2 2023 in Review
Gagnon Securities sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 66,957 shares — an estimated $664K sold.
Gagnon Securities first reported a position in APEN in Q2 2018 and held it in 20 quarters. The position peaked at $17M in Q4 2022. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- Gagnon Securities reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- Gagnon Securities sold 66,957 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $664K.
- Gagnon Securities first reported a position in Apollo Endosurgery, Inc. in Q2 2018 and held it in 20 quarters.
- Gagnon Securities's Apollo Endosurgery, Inc. position peaked at $17M in Q4 2022.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on Gagnon Securities's 13F filing for Q2 2023, filed 8 Aug 2023.